Gene · 8519
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses. | Cell Rep | 2023 | 37355988 | PubTator, text mining | PubMed |
| Interferon-induced transmembrane protein 3 in hepatocellular carcinoma patients. | BMC Cancer | 2023 | 37353775 | PubTator, text mining | PubMed |
| High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma. | Front Endocrinol (Lausanne) | 2023 | 37347110 | PubTator, text mining | PubMed |
| A new human embryonic cell type associated with activity of young transposable elements allows definition of the inner cell mass. | PLoS Biol | 2023 | 37339119 | PubTator, text mining | PubMed |
| Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis. | Front Immunol | 2023 | 37325639 | PubTator, text mining | PubMed |
| m6A reader proteins: the executive factors in modulating viral replication and host immune response. | Front Cell Infect Microbiol | 2023 | 37325513 | PubTator, text mining | PubMed |
| Interferon-Induced Transmembrane Protein 3 rs34481144 C/T Genotype and Clinical Parameters Related to Progression of COVID-19. | J Immunol Res | 2023 | 37323564 | PubTator, text mining | PubMed |
| Oral administration of D-glucosamine confers broad-spectrum protection against human coronaviruses including SARS-CoV-2. | Signal Transduct Target Ther | 2023 | 37311738 | PubTator, text mining | PubMed |
| Antiviral response and immunopathogenesis of interleukin 27 in COVID-19. | Arch Virol | 2023 | 37310504 | PubTator, text mining | PubMed |
| An inflammatory-related genes signature based model for prognosis prediction in breast cancer. | Oncol Res | 2023 | 37304237 | PubTator, text mining | PubMed |
| The human lncRNA GOMAFU suppresses neuronal interferon response pathways affected in neuropsychiatric diseases. | Brain Behav Immun | 2023 | 37301236 | PubTator, text mining | PubMed |
| The Essential Role of microRNAs in Inflammatory and Autoimmune Skin Diseases-A Review. | Int J Mol Sci | 2023 | 37298095 | PubTator, text mining | PubMed |
| Exploring the Expression of the «Dark Matter» of the Genome in Mesothelioma for Potentially Predictive Biomarkers for Prognosis and Immunotherapy. | Cancers (Basel) | 2023 | 37296931 | PubTator, text mining | PubMed |
| A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments. | Cancers (Basel) | 2023 | 37296850 | PubTator, text mining | PubMed |
| A Kaposi's sarcoma-associated herpes virus-encoded microRNA contributes to dilated cardiomyopathy. | Signal Transduct Target Ther | 2023 | 37291118 | PubTator, text mining | PubMed |
| Nucleic acid biomarkers of immune response and cell and tissue damage in children with COVID-19 and MIS-C. | Cell Rep Med | 2023 | 37279751 | PubTator, text mining | PubMed |
| Interplay of host and viral factors in inflammatory pathway mediated cytokine storm during RNA virus infection. | Curr Res Immunol | 2023 | 37273890 | PubTator, text mining | PubMed |
| Inborn errors of human B cell development, differentiation, and function. | J Exp Med | 2023 | 37273190 | PubTator, text mining | PubMed |
| Dysregulated early transcriptional signatures linked to mast cell and interferon responses are implicated in COVID-19 severity. | Front Immunol | 2023 | 37261339 | PubTator, text mining | PubMed |
| Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas. | Haematologica | 2023 | 37259566 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8519/papers?page=18